Drug Screening Using Novel IMD in Renal Cell Carcinoma

This study uses a specialized laboratory device to test cancer drugs directly on tumor tissue removed from kidney cancer patients — aiming to identify which drugs work best for each individual before treating them, a step toward personalized cancer care. **You may be eligible if...** - You are 18 or older with confirmed or suspected metastatic renal cell carcinoma (kidney cancer that has spread) - You are already scheduled for surgery to remove your kidney or a metastatic lesion as part of your standard care - The lesion being removed is at least 1 cm in size - You are medically stable enough for both surgery and biopsy procedures **You may NOT be eligible if...** - You have blood clotting disorders or are on anticoagulants that cannot be safely managed - Your tumor tissue cannot be safely biopsied or removed Talk to your doctor to see if this trial is right for you.